Last updated 2026-08-24
- Raised $200M debt round, Sep 2025
- Raised $28M Series B led by a16z crypto, Jul 2025
- Raised $11M Seed round led by Daniel Gross, May 2024
Total raised
$239.0M
Stage
—
Founded
2025
Headcount
—
HQ
Tel Aviv, Israel
Sector
Digital Health
About
Espresso Clinical is an AI-powered platform designed to modernize clinical operations. It introduces a smarter monitoring experience to improve site performance and data quality from day one. The platform features live deviation detection, actionable CRA guidance, site behavior tracking, compliance alignment, and closed-loop follow-up automation. It aims to empower clinical operations with real-time execution by augmenting workflows with intelligent AI agents, shifting from static site reports to dynamic, data-driven oversight.
Funding history · 3 rounds · $239.0M total
2025-09
Debt Financing
$200.0M
2025-07
B Round
$28.0M
★ a16z crypto
2024-05
Seed
$11.0M
★ Daniel Gross★ Nat Friedman
Q&A
- What is Espresso Clinical Ltd.'s primary business?
- Espresso Clinical Ltd. develops an AI-powered site monitoring tool for clinical operations professionals, aiming to make clinical trials faster, safer, and more successful through dynamic, data-driven oversight and proactive risk detection.
- When was Espresso Clinical Ltd. founded?
- Espresso Clinical Ltd. was founded in 2025.
- Who is the CEO and Co-Founder of Espresso Clinical Ltd.?
- Yoran Bar is the CEO and Co-Founder of Espresso Clinical Ltd., appointed in June 2025.
- What is Espresso Clinical Ltd.'s primary sector?
- Espresso Clinical Ltd.'s primary sector is Digital Health.
- Which technologies does Espresso Clinical Ltd. utilize?
- Espresso Clinical Ltd. utilizes Artificial Intelligence as a core technology for its platform.
- What type of customers does Espresso Clinical Ltd. target?
- Espresso Clinical Ltd. targets clinical operations professionals, pharmaceutical companies, and research organizations.
- How much Seed funding did Espresso Clinical Ltd. raise and when?
- Espresso Clinical Ltd. raised $11,000,000 in Seed funding in May 2024, with lead investors Daniel Gross.
- When did Espresso Clinical Ltd. secure its B Round funding and from whom?
- Espresso Clinical Ltd. secured $28,000,000 in B Round funding in July 2025, with a16z crypto as the lead investor.
- What was the most recent financing event for Espresso Clinical Ltd.?
- In September 2025, Espresso Clinical Ltd. secured $200,000,000 in Debt Financing.
Team · 1
Yoran Bar
Founder · CEO & Co-Founder
Sectors & technology
Primary sector
Digital Health
Technologies
Target customers
Business model
B2B
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | espressoclinical.com |
|---|
Identifiers & details
| Legal name | Espresso Clinical Ltd. |
|---|---|
| Founded | 2025 |
Radar intelligence
Web history (Wayback)
| Domain | espressoclinical.com |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 517175287 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2025-06-10 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Active charges / liens | 1 |
| Registry events | 2 — people (1), charge (1) |
| Registered address | תוצרת הארץ 7 תל אביב - יפו |
Recent registry events
| Date | Event |
|---|---|
| 2026-02-15 | עדכון דירקטורים-הסרת דירקטור |
| 2026-02-12 | רישום שעבוד |